Medications for Hepatocellular Carcinoma

17 results
Genentech, Inc.
Usage: Avastin is indicated for the treatment of various cancers, including metastatic colorectal cancer (in combination with chemotherapy), non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, cervical cancer, and advanced ovarian cancers (both sensitive and resistant). Additionally, it is used for unresectable hepatocellular carcinoma.
Exelixis, Inc.
Usage: CABOMETYX is indicated for advanced renal cell carcinoma (RCC), in combination with nivolumab for first-line treatment; hepatocellular carcinoma (HCC) after sorafenib; differentiated thyroid cancer (DTC) in patients aged 12 and older with prior VEGFR therapy failure; and well-differentiated neuroendocrine tumors (pNET and epNET) in patients aged 12 and older.
Eli Lilly and Company
Usage: CYRAMZA is indicated for treating adults with advanced or metastatic gastric cancer, non-small cell lung cancer (NSCLC), colorectal cancer, and hepatocellular carcinoma. It is used alone or in combination with specific chemotherapy agents, depending on disease progression and specific tumor characteristics.
AstraZeneca Pharmaceuticals LP
Usage: IMFINZI is indicated for treating various cancers in adults, including non-small cell lung cancer (both resectable and unresectable), small cell lung cancer (limited and extensive stage), biliary tract cancers, unresectable hepatocellular carcinoma, mismatch repair deficient endometrial cancer, and muscle invasive bladder cancer, often in combination with other therapies.
Qilu Pharmaceutical Co., Ltd.
Usage: Irinotecan hydrochloride injection is indicated for first-line therapy in combination with 5-fluorouracil and leucovorin for metastatic colorectal carcinoma and for patients whose disease has recurred or progressed after initial fluorouracil-based treatment.
Apotex Corp.
Usage: Irinotecan hydrochloride injection is indicated for first-line therapy in combination with 5-fluorouracil and leucovorin for metastatic colon or rectal carcinoma, and for patients with recurrent or progressed disease following initial fluorouracil-based therapy.
Areva Pharmaceuticals,Inc.
Usage: Irinotecan hydrochloride injection is indicated for first-line therapy in combination with 5-fluorouracil and leucovorin for metastatic colon or rectal carcinoma, and for patients whose disease has recurred or progressed after initial fluorouracil-based treatment.
Merck Sharp & Dohme LLC
Usage: KEYTRUDA® is indicated for treating various cancers, including melanoma, non-small cell lung cancer, malignant pleural mesothelioma, head and neck squamous cell cancer, classical Hodgkin lymphoma, and possible others, in both adults and children, depending on specific tumor characteristics and treatment history.
Jubilant DraxImage Inc., dba Jubilant Radiopharma
Usage: Technetium Tc 99m Sulfur Colloid Injection is used in adults to localize lymph nodes in breast cancer or malignant melanoma, evaluate peritoneo-venous shunt patency, and for imaging functioning reticuloendothelial cells in the liver, spleen, and bone marrow, as well as assessing esophageal transit and gastroesophageal reflux.
Eisai Inc.
Usage: LENVIMA is indicated for adult patients with radioactive iodine-refractory differentiated thyroid cancer, advanced renal cell carcinoma (both as first-line and following prior anti-angiogenic therapy), unresectable hepatocellular carcinoma, and advanced endometrial carcinoma that is mismatch repair proficient or not microsatellite instability-high.